Related Experiment Video
Updated: Aug 12, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Novel hepatitis agents: the significance of clinical and experimental studies. An overview
1Hepatitis Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Abstract:
A new virus with genomic organization similar to that of the family Flaviviridae was identified in patients with viral hepatitis and designated hepatitis G virus (HGV) or hepatitis GB virus C (GBV-C). HGV/GBV-C can be transmitted by blood and results in persistent infection, as shown in patients with posttransfusion non-A, non-B hepatitis, in transfusion recipients, and in donors of blood received by HGV-positive patients. The parenteral route of transmission of HGV/GBV-C infection was confirmed in experimentally infected chimpanzees. Epidemiologic studies of sporadic, community-acquired viral hepatitis have not indicated an association between HGV/GBV-C and acute non A-E hepatitis. Thus, the disease association of this new virus remains unconfirmed and its role in the etiology of acute and chronic hepatitis is unclear. The experimental model of HGV/GBV-C infection may define the biology of the virus replication.
Related Concept Videos
Hepatic Drug Excretion: Influencing Factors
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction

